Showing results (2091-2100 of 2,252) with videos related to
Sort By:
Pageof 226
The American Journal of Cardiology|November 6, 2017
Coronary Computed Tomographic Angiography-Derived Fractional Flow Reserve for Therapeutic Decision MakingChristian Tesche, Rozemarijn Vliegenthart, Taylor M Duguay, et al.The International Journal on Drug Policy|August 19, 2015
Recommendations for the management of hepatitis C virus infection among people who inject drugsJason Grebely, Geert Robaeys, Philip Bruggmann, et al.Kidney International Reports|November 13, 2024
Age-Related Differences in Rejection Rates, Infections, and Tacrolimus Exposure in Pediatric Kidney Transplant Recipients in the CERTAIN RegistryMaral Baghai Arassi, Manuel Feißt, Kai Krupka, et al.Immunity, Inflammation and Disease|December 11, 2024
Post-COVID immunity in patients with solid tumor or hematological malignancies treated with SARS-CoV-2 monoclonal antibodiesGilberto Sabino-Santos, Cathryn E Leggio, Sean M Litwin, et al.Journal of Medical Internet Research|June 2, 2023
A Video-Observed Treatment Strategy to Improve Adherence to Treatment Among Persons Who Inject Drugs Infected With Hepatitis C Virus: Qualitative Study of Stakeholder Perceptions and ExperiencesAlison Karasz, Krupa Merchant, Julia Arnsten, et al.Pediatric Nephrology (Berlin, Germany)|January 26, 2025
Factors associated with statural growth in pediatric kidney transplant recipients with focus on metabolic acidosisAgnieszka Prytuła, Dries Reynders, Els Goetghebeur, et al.The Journal of Biological Chemistry|March 1, 2017
A novel role for the Wnt inhibitor APCDD1 in adipocyte differentiation: Implications for diet-induced obesityNicole K H Yiew, Tapan K Chatterjee, Yao Liang Tang, et al.BMC Infectious Diseases|February 23, 2024
Overreporting of adherence to hepatitis C direct-acting antiviral therapy and sustained virologic response among people who inject drugs in the HERO studySnehal S Lopes, Irene Pericot-Valverde, Paula J Lum, et al.Journal of Viral Hepatitis|October 31, 2013
The new paradigm of hepatitis C therapy: integration of oral therapies into best practicesN H Afdhal, S Zeuzem, R T Schooley, et al.Drug and Alcohol Dependence|May 7, 2023
Injecting practices during and after hepatitis C treatment and associations with not achieving cure among persons who inject drugsJudith I Tsui, Paula J Lum, Lynn E Taylor, et al.Pageof 226